The estimated Net Worth of Wen Tao Liu is at least $4.9 Million dollars as of 10 April 2018. Mr. Liu owns over 22,444 units of Cellular Biomedicine Inc stock worth over $4,446,120 and over the last 10 years he sold CBMG stock worth over $275,000. In addition, he makes $179,560 as Independent Director at Cellular Biomedicine Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Liu CBMG stock SEC Form 4 insiders trading
Wen has made over 3 trades of the Cellular Biomedicine Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 22,444 units of CBMG stock worth $348,555 on 10 April 2018.
The largest trade he's ever made was exercising 33,333 units of Cellular Biomedicine Inc stock on 1 June 2015 worth over $99,999. On average, Wen trades about 8,347 units every 131 days since 2014. As of 10 April 2018 he still owns at least 225,120 units of Cellular Biomedicine Inc stock.
You can see the complete history of Mr. Liu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wen Liu biography
Dr. Wen Tao Liu Ph.D. serves as Independent Director of the Company. Mr. Liu has over 30 years of professional career encompassing biomedicine, clean energy and semiconductor industries. He has led multi-national businesses as well as entrepreneurial companies, with a proven track record of delivering financial results and shareholder value. Prior to joing the Company, Mr. Liu served on board of directors of various public and private companies in the United States, China, Hong Kong, Canada, and Australia. Mr. Liu previously served as Chairman and CEO of Cellular Biomedicine Group Inc fromMarch, 2012 to September, 2013. In October 2013, he transitioned to the role of Executive Chairman of the Board and, in February 2016, to the role of director and strategic advisor to CBMG’s management. Prior to CBMG, Mr. Liu served as President and CEO of Seeo Inc. from July 2010 to Feb 2012, and as director to Aug 2015 where he led a team of scientistsand entrepreneurs for the development of solid-state lithium ion battery for electric vehicles and smart grid applications. Under his leadership, Seeo received multiple funding from Department of Energy and venture capital firms. Seeo was elected to Global Cleantech 100 and top Energy Technology Startups in 2011.
What is the salary of Wen Liu?
As the Independent Director of Cellular Biomedicine Inc, the total compensation of Wen Liu at Cellular Biomedicine Inc is $179,560. There are 3 executives at Cellular Biomedicine Inc getting paid more, with Andrew Chan having the highest compensation of $847,684.
How old is Wen Liu?
Wen Liu is 64, he's been the Independent Director of Cellular Biomedicine Inc since 2018. There are 2 older and 7 younger executives at Cellular Biomedicine Inc. The oldest executive at Cellular Biomedicine Group Inc is Edward Schafer, 74, who is the Non-Executive Independent Director.
What's Wen Liu's mailing address?
Wen's mailing address filed with the SEC is C/O CELLULAR BIOMEDICINE GROUP, INC., 9605 MEDICAL CENTER DR, SUITE 100, ROCKVILLE, MD, 20850.
Insiders trading at Cellular Biomedicine Inc
Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao, and Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.
What does Cellular Biomedicine Inc's logo look like?
Complete history of Mr. Liu stock trades at Cellular Biomedicine Inc
Cellular Biomedicine Inc executives and stock owners
Cellular Biomedicine Inc executives and other stock owners filed with the SEC include:
-
Andrew Chan,
Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer, Secretary -
Bizuo Liu,
Chief Executive Officer, Chief Financial Officer, Director -
Yihong Yao,
Chief Scientific Officer -
Wen Liu,
Independent Director -
Terry Belmont,
Independent Chairman of the Board -
Hansheng Zhou,
Independent Director -
Chun Kwok Alan Au,
Independent Director -
Edward Schafer,
Non-Executive Independent Director -
Gang Ji,
Independent Director -
Sarah Kelly,
Director of Corporate Communications -
Darren O'Brien,
Independent Director -
Health Investment Holdings ...,
-
Wei (William) Cao,
Chief Executive Officer -
Bosun Hau,
-
Tony Liu,
CEO, CFO -
Nadir Patel,
-
Pak To Venture Garden Ltd F...,
-
David Bolocan,
Director -
Keith Wong,
Director -
Jianping Dai,
Director